| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| General and administrative | $6.5M+6.1% | $6.1M+1.8% | $6.0M+2.6% | $5.8M |
| Research and development | $11.5M-28.6% | $16.1M+35.6% | $11.9M+38.3% | $8.6M |
| Total operating expenses | $18.0M-19.1% | $22.2M+24.3% | $17.9M+23.9% | $14.4M |
| Loss from operations | -$18.0M+19.1% | -$22.2M-24.3% | -$17.9M-23.9% | -$14.4M |
| Interest income | $438K-41.0% | $742K-3.0% | $765K+274.5% | $204K |
| Other income, net | $421K-39.2% | $693K-39.8% | $1.2M+3747.3% | -$32K |
| NET LOSS | -$17.1M+17.6% | -$20.8M-30.2% | -$16.0M-11.9% | -$14.3M |
| Net loss per share of common shares, basic | -$1.57+18.7% | -$1.93-31.3% | -$1.47-12.2% | -$1.31 |
| Net loss per share of common shares, diluted | -$1.57+18.7% | -$1.93-31.3% | -$1.47-12.2% | -$1.31 |
| Weighted-average number of common shares outstanding, basic | 10.9M+1.3% | 10.8M-0.7% | 10.8M-0.1% | 10.9M |
| Weighted-average number of common shares outstanding, diluted | 10.9M+1.3% | 10.8M-0.7% | 10.8M-0.1% | 10.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.